Abstract
The recent published article ‘Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions’ by Larose et al caught our attention [1]. Larose and colleagues compared surgery-based trimodality therapy to medical therapy in malignant pleural mesothelioma (MPM) at two university hospitals. The authors conclude that aggressive therapy of MPM using cancer-directed surgery, systemic chemotherapy, and prophylactic radiotherapy may provide a significant survival benefit in selected patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
